xxii Time2shine

Search

New member
Joined
Nov 26, 2010
Messages
519
Tokens
Do the research, its everywhere now. Closed today at .65. This is no pump and dump. Long term 1 year-2year hold at least.Estimates are at 5.00 by spring time. Good company, good people, phase three clinical studies should be complete by years end. That means fast track FDA approval, that means $$.
Play with it for now,or just watch monthly, buy it and hold. Enjoy!
 

New member
Joined
Nov 26, 2010
Messages
519
Tokens
Most volume in history around 35k.....after averaging minimal 4-5k?? Why?? Keep watching...get in under a dollar while you can. Just a gift for now.
 

New member
Joined
Nov 26, 2010
Messages
519
Tokens
New news comes out again...passes phase 2 clinical studies and now into phase 3...blowing away any other way to help quit smoking..... this company is on fastrack for fda approval,( that rarely ever happens).....when it passes fda approval and the bigboys put it out to buy you will wish you bought below a dollar. A true gift from me to you. BILLeive boys, its a local Buffalo thing.
 

New member
Joined
Nov 26, 2010
Messages
519
Tokens
Look out folks....its real!!!
NY Times confirms validity and highest volume day in history today.
Again, long term play.....and when FDA approves...its a go!!!!!!!!!!!!!!!!!
Enjoy.
 

New member
Joined
Nov 26, 2010
Messages
519
Tokens
Results coming out this month!

Buy it.period



if you done your research or have questions pm direct
 

New member
Joined
Sep 21, 2004
Messages
6,814
Tokens
89 cents/sh on 1,500 volume.???..>>

lol

wtf
 

New member
Joined
Nov 26, 2010
Messages
519
Tokens
be patient....this is a real company (in some debt)......if you look close at sec filings( they just did a raise, and will do 1 more)....that will change the way people quit smoking and make a statement to the world reducing cancer( from quitting cigarettes)....and that's just one of the products.....(7-1 tar ratio for another product....top brands are 13-1 tar ratio....and no longer allowed to claim "light" cigarettes anymore).....99 patents in 79 countries....they beat "big tobacco" at their own game.....IMO.....according to public news....next news to come out with show final results of phase 2 clinical studies by gov. ( to be put out late december).......news will comes out....stock climbs because of news....15 mil raise in early 2012 for phase 3 study( just more people in the study).......fda approval....then look out....its a gift...lol if you want......pm if you like....

btw....as per past article....gov purchased 9million "test cigarettes"........big time cancer research institutes taking notice all over the world....

if you ever were prescribed chantix to quit smoking(highest quit rate).....well look at the side effects below link
http://www.google.com/url?sa=t&rct=...0_jNDQ&usg=AFQjCNEtiqPo0ZcWDpZK1nCHataVfnhiyw


with this product there are NO side effects....also, through 2 studies, both gov and independent.....quit rate is significantly higher than chantix............i just wish i had 100k to get in on the inside.....
 

New member
Joined
Nov 26, 2010
Messages
519
Tokens
By week's end, more news and national coverage. Get in under $1.00. It's a gift!
Conclusion

At the moment, however, this innovative microcap remains largely unnoticed by Wall Street. Besides, Elemer Piros, Ph.D., Rodman & Renshaw analyst who covers 22nd Century (with a 12-month price target of $5.00 for the now $1 stock), very few have given XXII much notice. For precisely this reason, 22nd Century is worth a careful look now. Keep in mind the following:

• Three independent Phase II trials have already demonstrated efficacy of very low nicotine cigarettes for smoking cessation. If the company-sponsored Phase II-B clinical trials that are now underway simply replicate the results of the Hatsukami study, X-22 will be seen as perhaps the most effective smoking cessation aid in the world;

• No other tobacco or pharmaceutical company in the world can produce tobacco cigarettes at the levels of 22nd Century’s VLN tobacco. If the FDA mandates drastically lower nicotine levels in commercial cigarettes – or if 22nd Century is authorized to market its cigarettes as “Modified Risk” – the company will have massive licensing opportunities domestically and world-wide;

• XXII is already generating revenue. Operating losses are minimal. Based on 22nd Century’s reported revenue for the nine months ended September 30, 2011 totaling $1.02 million, including net sales of $802 thousand, and de minimis Q3 quarter net loss of only $.02/share, the company is well on its way to commercializing its high margin products.

Late this week, investors in XXII can look forward to seeing results in the company’s Phase II-B clinical trial which should be followed by the likely filing for fast track status for their X-22 prescription smoking aid with the FDA. In 2012, the company expects to continue its sales of SPECTRUM government research cigarettes, begin marketing “Nicotine-Free” and “High Nicotine/Low Tar” safer cigarettes internationally, and will expand distribution of its super-premium RED SUN cigarettes in the U.S. Each of these initiatives represents substantial sales potential.

At today’s market cap of just $28 million, there is plenty of headroom for this undiscovered stock to run. This appears to be a safe horse to bet on ahead of key clinical trial results and beyond given the interest in the company from the entire industry.


full article below:
http://www.biomedreports.com/201112...the-smoking-cessation-industry-this-week.html
 

New member
Joined
Feb 5, 2007
Messages
3,415
Tokens
in for 2400 shares...looks like she moves swiftly on volume...volume coming end of the week on the trial report
 

Forum statistics

Threads
1,106,767
Messages
13,438,805
Members
99,337
Latest member
hbs_solutions
The RX is the sports betting industry's leading information portal for bonuses, picks, and sportsbook reviews. Find the best deals offered by a sportsbook in your state and browse our free picks section.FacebookTwitterInstagramContact Usforum@therx.com